Skip to content

Clinical trials

Breast Carcinoma In Situ trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Carcinoma In Situ Country / region: United States Clear all

151 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20026
20035
20044
200510
20067
20077
20087
20093
20105
20112
20122
20136
20141
20158
20167
20177
20188
20195
20207
202112
20222
20237
20247
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed91
Recruiting20
Active, not recruiting15
Terminated15
Unknown status4
Suspended3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic13
National Cancer Institute (NCI)11
Ohio State University Comprehensive Cancer Center10
Alliance for Clinical Trials in Oncology6
Jonsson Comprehensive Cancer Center6
City of Hope Medical Center5
SWOG Cancer Research Network5
M.D. Anderson Cancer Center4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
Wake Forest University Health Sciences4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Carcinoma In Situ151
Breast Neoplasms114
Carcinoma, Intraductal, Noninfiltrating80
Carcinoma, Lobular11
Carcinoma, Ductal, Breast10
Hot Flashes10
Breast Neoplasms, Male6
Fatigue5
Triple Negative Breast Neoplasms5
Pain4

Trials

Showing 1 to 25 of 151. Each trial links to its page on Pharma Observatory.

51 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.